I Koza
Impact in
-
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Neutropenia and Cancer Infections
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 22
- Cancer Treatment and Pharmacology 9
- Neutropenia and Cancer Infections 6
- Colorectal Cancer Treatments and Studies 4
- Lung Cancer Research Studies 4
- Co-authors
- Jozef Mardiak (9 shared papers)Michal Mego (8 shared papers)Zuzana Syčová-Milá (8 shared papers)Mária Rečková (6 shared papers)Jana Obertová (7 shared papers)J. Trupl (4 shared papers)L. Ebringer (2 shared papers)Ľuboš Drgoňa (2 shared papers)
In The Last Decade
I Koza
35 papers receiving 341 citations
Peers
Comparison fields: 5 of 66
- Oncology 174
- Cancer Research 31
- Hematology 23
- Reproductive Medicine 13
- Surgery 65
Countries citing papers authored by I Koza
This map shows the geographic impact of I Koza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Koza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Koza more than expected).
Fields of papers citing papers by I Koza
This network shows the impact of papers produced by I Koza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Koza. The network helps show where I Koza may publish in the future.
Co-authors
The 25 scholars most cited alongside I Koza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 90 | |
| 2 | Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study. | 2005 | 40 |
| 3 | 2005 | 32 | |
| 4 | Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I. | 2005 | 28 |
| 5 | Adjuvant clodronate therapy in patients with locally advanced breast cancer--long term results of a double blind randomized trial. Slovak Clodronate Collaborative Group. | 2000 | 16 |
| 6 | 1990 | 14 | |
| 7 | Histocompatible leukocyte transfusion during granulocytopenia. | 1971 | 13 |
| 8 | Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study. | 2007 | 11 |
| 9 | 2008 | 9 | |
| 10 | Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study. | 2005 | 9 |
| 11 | 2011 | 7 | |
| 12 | Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG). | 1990 | 7 |
| 13 | Sequential development of chronic lymphocytic leukemia in a patient with polycythemia vera. | 1988 | 7 |
| 14 | 2008 | 6 | |
| 15 | Immunosuppression with cyclophosphamide: effect on antibody plaque-forming spleen cells and on hemolytic antibodies production. | 1972 | 6 |
| 16 | 2009 | 6 | |
| 17 | Single versus combination chemotherapy of L1210 leukemia. | 1980 | 5 |
| 18 | 1990 | 5 | |
| 19 | 2009 | 4 | |
| 20 | 2009 | 4 |
About I Koza
I Koza is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Neurology, having authored 40 papers that have together received 352 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Testicular diseases and treatments (7 papers), Neutropenia and Cancer Infections (6 papers), Neuroblastoma Research and Treatments (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Research Studies (4 papers), Cancer therapeutics and mechanisms (4 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Oncology (174 citations), Cancer Research (31 citations), Hematology (23 citations), Reproductive Medicine (13 citations) and Surgery (65 citations). I Koza has collaborated with scholars based in Slovakia, Czechia and India. Frequent co-authors include Jozef Mardiak, Michal Mego, Zuzana Syčová-Milá, Mária Rečková, Jana Obertová, J. Trupl, L. Ebringer, Ľuboš Drgoňa, Vladimír Zajac and Alessandra Fabi. Their work appears in journals such as Journal of Clinical Oncology, Chemotherapy, Mycoses, Oncology and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.